Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
Scientific Community
Become a Member | Sign in
Home>News>This Article

Improved Assays in Pain Research Using Native Neurons

Published: Saturday, May 10, 2014
Last Updated: Saturday, May 10, 2014
Bookmark and Share
Cellectricon and Neusentis to present a webinar on May 16, from 11am EDT.

Cellectricon will co-host a webinar with Neusentis, describing the use of native cells to develop an assay with improved physiological relevance over traditional approaches in pain drug discovery research.

Entitled ‘Development of Cell-Based Assays for Pain Drug Discovery Using Native Sensory Neurons’, the webinar will take place on May 16 at 11am EDT; researchers can register at

Cellectricon is creating model systems with native neurons for registering changes in neural activity - both at the cellular and network level - using its Cellaxess® Elektra discovery platform, and Neusentis is a Pfizer Research Unit focusing on pain and sensory disorders.

Webinar participants will gain further understanding of the underlying mechanisms causing chronic pain, and learn more about phenotypic screening approaches in pain research and the use of compound profiling to advance research in the CNS and pain therapeutic fields.

Presentations from Dr Darren Cawkill, Associate Research Fellow at Neusentis, and Dr Paul Karila, VP Discovery Services, Cellectricon, will cover the results from their assay development work. Dr Cawkill will go on to present data from an additional phenotypic screening case study, which describes the progress towards high-throughput compatible assays using both primary rat neuronal cultures and human stem cell-derived sensory neurons. There will also be a discussion on how such phenotypic screening assays could be integrated into drug discovery programs.

Aimed at R&D scientists working in drug discovery, neuroscience, translational science, high content biology, electrophysiology and ion channel research, ‘Development of Cell-Based Assays for Pain Drug Discovery Using Native Sensory Neurons’, will take place at 11am EDT on May 16.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cellectricon, Censo Biotechnologies Collaborate
Collaboration aims to offer high-quality human iPSC-based discovery services for CNS and pain research.
Friday, September 09, 2016
Cellectricon Receives Milestone Order for Cellaxess®HT High Throughput RNAi Screening System
Cellectricon receives the largest single order to deliver three Cellaxess®HT systems to a leading US biotech firm.
Friday, November 14, 2008
Scientific News
Genome Engineering Paves Way For Sickle Cell Cure
Researchers from UC Berkeley have used CRISPR-Cas9 gene editing to fix the mutated gene responsible for sickle cell disease.
Preventing Alzheimer's in Mice
Researchers have prevented the Alzheimer’s development in mice by using a virus delivery system to transport a specific gene into the brain.
Link Between Heart and Blood Cells in Early Development Found
Researchers have identifed a key factor in determining the fate of early undifferentiated cells during development.
Scientists Speed Up Muscle Repair
Researchers discovered genetically modified mice were able to support far more regenerative stem cells, for muscle repair, than previously thought.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Nanosensors Could Determine Tumours’ Ability to Remodel Tissue
Researchers design nanosensors that can profile tumours, focusing on protease levels.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
1960s Antibiotics Show Promise for TB Therapy
Research suggests antibiotics introduced in 1963 to treat bacterial infections show promise for tuberculosis therapy.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Studies Explore the Science of Cardiovascular Diseases
Two studies highlight how basic science research insights are key to future treatment breakthroughs.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos